News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,502 Results
Type
Article (46054)
Company Profile (331)
Press Release (718102)
Multimedia
Podcasts (134)
Webinars (23)
Section
Business (212873)
Career Advice (2157)
Deals (36665)
Drug Delivery (142)
Drug Development (82927)
Employer Resources (179)
FDA (17129)
Job Trends (15508)
News (358423)
Policy (33685)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2765)
Accelerated approval (55)
ADA (45)
Adcomms (29)
Allergies (197)
Alliances (52697)
ALS (230)
Alzheimer's disease (1864)
Antibody-drug conjugate (ADC) (536)
Approvals (17580)
Artificial intelligence (784)
ASCO (330)
Autoimmune disease (348)
Automation (66)
Bankruptcy (369)
Best Places to Work (11963)
BIO (67)
BIOSECURE Act (20)
Biosimilars (232)
Biotechnology (216)
Bladder cancer (206)
Brain cancer (78)
Breast cancer (814)
Cancer (6387)
Cardiovascular disease (511)
Career advice (1843)
Career pathing (47)
CAR-T (369)
CDC (61)
Celiac Disease (3)
Cell therapy (1000)
Cervical cancer (56)
Clinical research (72393)
Collaboration (2313)
Commercialization (1)
Company closure (7)
Compensation (1507)
Complete response letters (87)
COVID-19 (2846)
CRISPR (123)
C-suite (1272)
Cystic fibrosis (163)
Data (8697)
Decentralized trials (3)
Denatured (47)
Depression (178)
Dermatology (99)
Diabetes (671)
Diagnostics (7320)
Digital health (66)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (377)
Drug pricing (206)
Drug shortages (33)
Duchenne muscular dystrophy (309)
Earnings (93973)
Editorial (71)
Employer branding (22)
Employer resources (160)
Events (125625)
Executive appointments (1164)
FDA (21202)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1916)
Gene editing (260)
Generative AI (68)
Gene therapy (792)
GLP-1 (1116)
Government (4871)
Grass and pollen (7)
Guidances (421)
Healthcare (19917)
Hematology (192)
HIV (93)
Huntington's disease (64)
IgA nephropathy (113)
Immunology and inflammation (306)
Immuno-oncology (106)
Indications (218)
Infectious disease (3222)
Inflammatory bowel disease (228)
Inflation Reduction Act (14)
Influenza (146)
Intellectual property (324)
Interviews (340)
IPO (17030)
IRA (51)
Job creations (3847)
Job search strategy (1526)
JPM (63)
Kidney cancer (20)
Labor market (112)
Layoffs (600)
Leadership (46)
Legal (8182)
Liver cancer (106)
Longevity (35)
Lung cancer (835)
Lymphoma (475)
Machine learning (68)
Management (65)
Manufacturing (1179)
Marketing (3)
MASH (212)
Medical affairs (1)
Medical device (14757)
Medtech (14933)
Mergers & acquisitions (20956)
Metabolic disorders (1667)
mRNA (254)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (472)
Neuropsychiatric disorders (111)
Neuroscience (3529)
Neurotech (1)
NextGen: Class of 2026 (6875)
Non-profit (4692)
Now hiring (82)
Obesity (764)
Opinion (316)
Ovarian cancer (241)
Pain (269)
Pancreatic cancer (356)
Parkinson's disease (397)
Partnered (36)
Patents (649)
Patient recruitment (772)
Peanut (69)
People (62295)
Pharmaceutical (67)
Pharmacy benefit managers (34)
Phase 1 (22730)
Phase 2 (31875)
Phase 3 (23611)
Pipeline (9894)
Policy (345)
Postmarket research (2590)
Preclinical (9750)
Press Release (71)
Prostate cancer (339)
Psychedelics (58)
Radiopharmaceuticals (368)
Rare diseases (1190)
Real estate (6309)
Recruiting (71)
Regulatory (26481)
Reports (56)
Research institute (2570)
Resumes & cover letters (368)
Rett syndrome (45)
RNA editing (29)
RSV (92)
Schizophrenia (186)
Series A (330)
Series B (240)
Service/supplier (14)
Sickle cell disease (121)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3922)
State (2)
Stomach cancer (18)
Supply chain (136)
Tariffs (87)
The Weekly (84)
Vaccines (1193)
Venture capital (127)
Weight loss (488)
Women's health (141)
Worklife (22)
Date
Today (68)
Last 7 days (450)
Last 30 days (2570)
Last 365 days (31087)
2026 (16335)
2025 (31025)
2024 (36248)
2023 (41157)
2022 (52428)
2021 (57028)
2020 (55658)
2019 (48513)
2018 (36499)
2017 (33567)
2016 (33178)
2015 (39384)
2014 (32958)
2013 (28005)
2012 (30258)
2011 (30871)
2010 (28823)
Location
Africa (787)
Alabama (96)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (42699)
Australia (7112)
California (14223)
Canada (3971)
China (1526)
Colorado (606)
Connecticut (626)
Delaware (446)
Europe (94187)
Florida (2124)
Georgia (462)
Hawaii (3)
Idaho (66)
Illinois (1178)
India (97)
Indiana (645)
Iowa (25)
Japan (606)
Kansas (137)
Kentucky (54)
Louisiana (60)
Maine (76)
Maryland (1682)
Massachusetts (10307)
Michigan (406)
Minnesota (780)
Mississippi (7)
Missouri (160)
Montana (36)
Nebraska (30)
Nevada (153)
New Hampshire (91)
New Jersey (3731)
New Mexico (32)
New York (3725)
North Carolina (1817)
North Dakota (11)
Northern California (7151)
Ohio (435)
Oklahoma (25)
Oregon (45)
Pennsylvania (2809)
Puerto Rico (33)
Rhode Island (53)
South America (1175)
South Carolina (88)
South Dakota (2)
Southern California (5639)
Tennessee (233)
Texas (2297)
United States (50400)
Utah (425)
Vermont (2)
Virginia (352)
Washington D.C. (82)
Washington State (1141)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
764,502 Results for "align technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
June 2, 2026
·
4 min read
Press Releases
OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma
• Confirmatory Phase 3 trial to commence prior to BLA grant under Accelerated Approval Program in the U.S. and Conditional MAA in the U.K., Europe and Australia • Patent pending pharmacodynamic response biomarker accepted as surrogate clinical efficacy endpoint • TGA and MHRA agree to allow utilization of remaining Phase 2b drug product for initiation of confirmatory Phase 3 • FDA and EMA fully align with Company on Chemistry, Manufacturing and Controls (CMC) • Market access process initiated with UK NICE and EU JCA
June 8, 2026
·
6 min read
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
Incyte is acquiring Vega Therapeutics, a subsidiary of Star Therapeutics, for a bleeding disorder program that analysts say has “pipeline-in-a-product” potential.
June 8, 2026
·
2 min read
·
Annalee Armstrong
Vaccines
FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in February.
June 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Completion of Phase 1 Integration Aligns and Strengthens Gaelic and Athlone Labs
June 9, 2026
·
1 min read
Deals
Novartis, Antares stars align in cancer deal that could top $1.9B
Novartis and Antares Therapeutics are shooting for the stars, launching a joint mission to develop small molecule oncology therapies.
June 24, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
June 22, 2026
·
5 min read
Press Releases
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
March 4, 2026
·
13 min read
Press Releases
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
June 23, 2026
·
9 min read
Press Releases
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
May 8, 2026
·
4 min read
1 of 76,451
Next